Catalyst
Slingshot members are tracking this event:
BioLineRX (BLRX) Initiates Phase 2a Trial Evaluating BL-8040 + Merck's (MRK) KEYTRUDA in Treatment of Pancreatic Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 20, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Bl-8040, Keytruda, Pancreatic Cancer, Trial Initiation, Phase 2a
